These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16697259)

  • 1. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
    Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
    Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
    Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ
    J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retargeting of retroviral integration sites for the predictable expression of transgenes and the analysis of cis-acting sequences.
    Schübeler D; Maass K; Bode J
    Biochemistry; 1998 Aug; 37(34):11907-14. PubMed ID: 9718314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flp-mediated integration of expression cassettes into FRT-tagged chromosomal loci in mammalian cells.
    Wirth D; Hauser H
    Methods Mol Biol; 2004; 267():467-76. PubMed ID: 15269443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
    J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
    Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
    Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines.
    Gama-Norton L; Herrmann S; Schucht R; Coroadinha AS; Löw R; Alves PM; Bartholomae CC; Schmidt M; Baum C; Schambach A; Hauser H; Wirth D
    Hum Gene Ther; 2010 Aug; 21(8):979-91. PubMed ID: 20222806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.
    Hennig K; Raasch L; Kolbe C; Weidner S; Leisegang M; Uckert W; Titeux M; Hovnanian A; Kuehlcke K; Loew R
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):218-28. PubMed ID: 25381930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
    Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
    Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
    Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
    Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.
    von Rüden T; Stingl L; Cotten M; Wagner E; Zatloukal K
    Biotechniques; 1995 Mar; 18(3):484-9. PubMed ID: 7779400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable generation of stable high titer producer cell lines for gene therapy.
    Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M
    Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated strategy for the production of therapeutic retroviral vectors.
    Carrondo M; Panet A; Wirth D; Coroadinha AS; Cruz P; Falk H; Schucht R; Dupont F; Geny-Fiamma C; Merten OW; Hauser H
    Hum Gene Ther; 2011 Mar; 22(3):370-9. PubMed ID: 21043806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoactivatable retroviral vectors: a strategy for targeted gene delivery.
    Pandori MW; Sano T
    Gene Ther; 2000 Dec; 7(23):1999-2006. PubMed ID: 11175311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
    Lin X
    Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
    Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
    Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
    Chan LM; Coutelle C; Themis M
    Gene Ther; 2001 May; 8(9):697-703. PubMed ID: 11406764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
    Ghani K; Cottin S; Kamen A; Caruso M
    Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.